Literature DB >> 11906688

Genetic and functional analysis of single nucleotide polymorphisms in the beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2).

Kira K Lueders1, Stella Hu, Louise McHugh, Max V Myakishev, Leo A Sirota, Dean H Hamer.   

Abstract

The beta2-neuronal nicotinic acetylcholine receptor gene (CHRNB2) is a logical candidate for influencing smoking behavior and nicotine dependence. We discovered six single nucleotide polymorphisms (SNPs) in the CHRNB2 gene by surveying 15.4 kb of genomic sequence including a previously undescribed 3' untranslated region that extends 4.0 kb downstream of the coding region. One of the SNPs causes an amino acid substitution in exon 5, one occurs in the promoter region, one changes an intronic base, and three occur in the 3' untranslated region. The ethnically dependent allele frequencies and the marker-to-marker linkage disequilibrium patterns of five of these polymorphisms were determined. The SNPs were assayed in 743 individuals for whom information on smoking history and lifelong nicotine dependence was available. No significant associations of the individual markers or their haplotypes to smoking behavior or level of nicotine dependence were found.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11906688     DOI: 10.1080/14622200110098419

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN: 1462-2203            Impact factor:   4.244


  25 in total

1.  Environmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.

Authors:  Gary E Swan; Karen Suchanek Hudmon; Lisa M Jack; Kymberli Hemberger; Dorit Carmelli; Taline V Khroyan; Huijun Z Ring; Hyman Hops; Judy A Andrews; Elizabeth Tildesley; Dale McBride; Neal Benowitz; Chris Webster; Kirk C Wilhelmsen; Heidi S Feiler; Barbara Koenig; Lorraine Caron; Judy Illes; Li S-C Cheng
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-10       Impact factor: 4.254

2.  CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.

Authors:  N R Hoft; J A Stitzel; K E Hutchison; M A Ehringer
Journal:  Genes Brain Behav       Date:  2010-11-04       Impact factor: 3.449

Review 3.  Genetics and smoking cessation improving outcomes in smokers at risk.

Authors:  Caryn E Lerman; Robert A Schnoll; Marcus R Munafò
Journal:  Am J Prev Med       Date:  2007-12       Impact factor: 5.043

Review 4.  The genetics of nicotine dependence.

Authors:  Ming D Li
Journal:  Curr Psychiatry Rep       Date:  2006-04       Impact factor: 5.285

5.  Genome-wide association for nicotine dependence and smoking cessation success in NIH research volunteers.

Authors:  Tomas Drgon; Ivan Montoya; Catherine Johnson; Qing-Rong Liu; Donna Walther; Dean Hamer; George R Uhl
Journal:  Mol Med       Date:  2008-10-02       Impact factor: 6.354

Review 6.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

7.  Association of CHRN genes with "dizziness" to tobacco.

Authors:  Marissa A Ehringer; Matthew B McQueen; Nicole R Hoft; Nancy L Saccone; Jerry A Stitzel; Jen C Wang; Laura J Bierut
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-03-05       Impact factor: 3.568

8.  Nominal association with CHRNA4 variants and nicotine dependence.

Authors:  H M Kamens; R P Corley; M B McQueen; M C Stallings; C J Hopfer; T J Crowley; S A Brown; J K Hewitt; M A Ehringer
Journal:  Genes Brain Behav       Date:  2013-02-06       Impact factor: 3.449

Review 9.  Pharmacogenetics and smoking cessation with nicotine replacement therapy.

Authors:  Riju Ray; Robert A Schnoll; Caryn Lerman
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 10.  The genetic components of alcohol and nicotine co-addiction: from genes to behavior.

Authors:  Isabel R Schlaepfer; Nicole R Hoft; Marissa A Ehringer
Journal:  Curr Drug Abuse Rev       Date:  2008-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.